A, schematic representation of the “classic” role of uPAR in tumor biology. A, schematic representation of the “classic” role of uPAR in tumor biology.

Slides:



Advertisements
Similar presentations
SIGNALING FROM THE CELL SURFACE TO THE NUCLEUS
Advertisements

Neurotrophin Signaling (Trk Signaling Pathway). Neurotrophins The neurotrophins are a family of proteins that are essential for the development of the.
CHAPTER 9 LECTURE SLIDES
1 Molecular mechanism of cancer metastasis Dr. Yick-Pang Ching Department of Pathology Room L7-05, Faculty Medicine Building Tel: E.Mail:
Cell Communication Chapter 9. Please note that due to differing operating systems, some animations will not appear until the presentation is viewed in.
Mathematical Modelling of Cancer Invasion of Tissue: The Role of the Urokinase Plasminogen Activation System Mark Chaplain and Georgios Lolas Division.
ADAM introduction Nan Song 2004/3/20. ADAM Contain: A Disintegrin And Metalloprotease Domain Other names: –Cellular disintegrins –MDCs (metalloprotease/
Interaction of Cells with Other Cells (5)
Cell Junctions, Cell Adhesion, and the Extracellular Matrix.
Cell Communication Chapter 9.
Cell Communication Chapter 9. 2 Cell Communication Communication between cells requires: ligand: the signaling molecule receptor protein: the molecule.
Date of download: 6/3/2016 Copyright © American College of Chest Physicians. All rights reserved. Tissue Factor, Thrombin, and Cancer * Chest. 2003;124(3_suppl):58S-68S.
The Role of Cell Adhesion in Inflammation and Metastasis 赵燃 丁合
The interaction between uPAR and vitronectin triggers ligand ‐ independent adhesion signalling by integrins by Gian Maria Sarra Ferraris, Carsten Schulte,
Integrin signalling Vytášek 2010.
ANIMAL CELL CULTURE.
Angiogenesis and hepatocellular carcinoma
Overview of Cellular Signaling Mechanisms
CD146: a new partner for VEGFR2
Chemokines A class of proteins secreted by cells which functions to attract cells.
Inducing Angiogenesis
Volume 7, Issue 3, Pages (March 2005)
Activating Invasion and Metastasis
Cell Communication Chapter 9.
Communication within Multicellular Organisms
Another Notch on the belt
Potential pathways directly linking obesity with cancer.
HER2/HER3 heterodimers in prostate cancer
Tumor progression: Defining the soil round the tumor seed
Cells into Tissues By Kevin Huyen.
Cell Communication Chapter 6.
Cell Communication.
Integrin signalling Vytášek 2009.
Obstructive nephropathy: Insights from genetically engineered animals
Kindlins Current Biology
Figure 1 Activation and signalling of IL-1
Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism 
Stealing VEGF from Thy Neighbor
Mechanisms of myocardial reperfusion injury
Macrophages and Therapeutic Resistance in Cancer
Macrophages and Therapeutic Resistance in Cancer
A TeNaCious Foundation for the Metastatic Niche
A. Craig Lockhart, Mace L. Rothenberg, Jordan D. Berlin 
Angiogenesis and hepatocellular carcinoma
Lino Ferreira, Jeffrey M. Karp, Luis Nobre, Robert Langer 
Volume 9, Issue 19, (October 1999)
Wnt/β-catenin signaling and kidney fibrosis
R. Clive Landis, PhD, George Asimakopoulos, Mike Poullis, Dorian O
Schematic representation of mechanisms leading to the synergy of anti-CD137 and anti–PD-1 immunostimulatory mAbs. Schematic representation of mechanisms.
Steroid hormones: Interactions with membrane-bound receptors
Roles of fibrinolytic system components in the nervous system
Protein kinase Cα: disease regulator and therapeutic target
Nitric oxide and vascular remodeling: Spotlight on the kidney
SRC and STAT Pathways Journal of Thoracic Oncology
The promise of biomarkers for personalized renal cancer care
Yan Feng, MD, Praveena S. Thiagarajan, PhD, Patrick C. Ma, MD 
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
Volume 22, Issue 2, Pages (August 2012)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Matrix Metalloproteinases in Human Melanoma
Death in the CNS: Six-Microns-Under
Oxidative stress and apoptosis
EMT and proteinuria as progression factors
Inhibition of VEGF-R2-mediated signalling cascade by endogenous antagonists. Inhibition of VEGF-R2-mediated signalling cascade by endogenous antagonists.
Intracellular Signaling
Various impediments in the uptake and retention of radiolabeled antibodies in solid tumors and strategies to modulate these biological barriers. Various.
Brief Review – Growth Factors and Receptors
Human cancer immunotherapy strategies targeting B7-H3 A, blockade of B7-H3 with blocking mAbs neutralizes inhibitory signaling in its unidentified receptor(s)
Schematic presentation of pHLIP peptide (red) conjugated with fluorescent dye (yellow) interaction with plasma membrane of a normal cell in healthy tissue.
Model of the change in receptor structure on engagement of the ligand IFN-γ. Model of the change in receptor structure on engagement of the ligand IFN-γ.
Presentation transcript:

A, schematic representation of the “classic” role of uPAR in tumor biology. A, schematic representation of the “classic” role of uPAR in tumor biology. The ligand for uPAR, uPA, is a serine protease that mediates the activation of plasminogen to plasmin and this process occurs with greater catalytic efficiency when both molecules are bound to the cell surface (5). Once activated, plasmin unleashes several cascades leading to the degradation of ECM, the activation of pro-matrix metalloproteinases, and the activation and release of growth factors such as vascular endothelial growth factor that are deposited in the ECM (33–35). B, schematic representation of the role of uPAR in cell signaling. uPAR, despite being a glycosylphosphatidylinositol-anchored receptor and lacking a transmembrane domain, is capable of transmitting an intracellular signal. uPAR has several ligands/adaptors such as integrins that it associated with to form dynamic signaling complexes on the cell surface. The interactions with these non-uPA ligands may represent novel opportunities for the therapeutic targeting of uPAR (arrows). Andrew P. Mazar Clin Cancer Res 2008;14:5649-5655 ©2008 by American Association for Cancer Research